Havas Health Network

This is #RareNext - anticipating the future of #RareDisease. As we look to the future of rare, technology and AI have the potential to revolutionize care on a global scale. Not only in drug development, but across the patient experience. And human expertise is essential to guide the use of these technologies. In the third spotlight from the Havas Futures Report on Rare, we bring you insights into recent breakthroughs and the Havas Health Network view on how we can use them to drive meaningful progress for rare communities around the world. Download the Havas Futures Report on Rare: havasrarenext.com #RareNext #RareDiseaseDay #OneHavas

In the Havas Health Network sponsored issue of Rare Revolution Magazine this month, Havas Life London Group Creative Director Dick Dunford discusses the importance of creativity in communications, and our approach to reaching communities and healthcare professionals affected by rare diseases #RareDiseaseDay

This is #RareNext - examining the gaps in #RareDisease and solutions to close them. In our second spotlight, we examine the disconnect between types of data: findings generated by clinical trials with small populations, versus the reported - and often nuanced - real life experience of patients themselves. As the rare landscape evolves, there is an increasing recognition of the value of patient-reported outcomes and real-world evidence. But how can we harness this data at the right time and in the right way to achieve a common understanding of what is a meaningful outcome? We are committed to championing meaningful data that demonstrates value - find out how in the Havas Futures Report on Rare. Download the Futures Report now: havasrarenext.com #RareNext #RareDiseaseDay #OneHavas

“Shape Shifting: A Close Look at the Health and Wellness Disruptor — GLP-1” is happening in Paris on March 13th! Check out the full agenda and get ready for expert-led discussions on the science, behavior shifts, economic potential, and cultural impact of GLP-1s. Whether you’ll be there in person or joining us virtually, we’re thrilled to have you with us! For those joining us in person, there will be a cocktail hour to follow. Interested in attending? RSVP here: https://lnkd.in/emdJHFW3 For more information about the event, please email global.comms@havas.com! #OneHavas #MeaningfulDifference #GLP1

I'm not usually one to get personal on LinkedIn, but here we are. Living with Ankylosing Spondylitis (#AS) has been a challenging journey—one I didn’t even realize I was on for a decade. AS affects 0.1–1% of the global population, yet it often goes undiagnosed for far too long. Throughout my teens and early 20s, I dealt with persistent, unexplained pain in my hips, assuming it was just growing pains—something I had to push through. Being diagnosed at 23 was both a relief and an adjustment, especially after learning that AS is more commonly seen in men, making my path to diagnosis even more complicated. It’s still surreal to rely on medication every day just to do something as simple as walking without pain. Managing AS is a constant balance of movement, rest, and listening to what my body needs. While it’s not easy, it has taught me resilience, self-advocacy, and how to live with something most people can’t see but I feel every day. So why am I sharing this? Because sharing our stories is one of the most powerful ways we can raise awareness and help others feel less alone in their rare disease journey. I’m grateful to be supporting the future of where rare goes next and making a meaningful difference for Rare Disease Day 2025 with Havas Health Network. #RareNext #RareDiseaseDay #RDD #AnkylosingSpondylitis #OneHavas #HavasHealth #HavasLife #MeaningfulDifference Havas Life London Havas Life Rare

“We hear patients say they feel like a science experiment” with physicians who aren’t knowledgeable about their rare disease - Ania Ermarkaryan Our COE panelists for #RareNext, talking about the unique perspectives of each stakeholder in the rare community #havashealth making a #meaningfuldifference in #raredisease

Calling all emerging creatives! Havas Health is searching for the next generation of Art Directors, Copywriters, and Designers to join our Junior Creative Fellowship—a paid summer internship designed to jumpstart your career. If you’re a recent grad, senior, or entry-level creative with big ideas, a unique perspective, and a passion for storytelling, this is your chance to learn, grow, and create alongside some of the best in the industry. What’s in it for you? ✔️ Hands-on experience across Havas Health agencies in NYC ✔️ Mentorship from industry pros ✔️ Networking with top creative minds Program Dates: June 2 – August 8, 2025 Apply by: March 7, 2025 Location: New York (Midtown & Tribeca offices) Eligibility: Must be based in the U.S. and authorized to work (no sponsorship provided). Ready to make your mark? Apply now: https://lnkd.in/ekY8QzHa #OneHavas #MeaningfulDifference 

This is #RareNext - creating meaningful connections in #RareDisease. The practical difficulties experienced during people’s “diagnostic odyssey” are understood throughout the rare community. But the emotional burden is less widely acknowledged, is just as damaging, and can persist long after diagnosis. At Havas Health Network, we believe that by creating meaningful connections with all stakeholders in the rare community we can help build a culture of transparency, manage expectations and support patients and their loved ones on every step of their journey. Find out more in our first spotlight from the Havas Futures Report on Rare . Download the Futures Report now: havasrarenext.com #RareNext #RareDiseaseDay #OneHavas

Columbia Beauty Club is hosting its 3rd Annual Beauty Summit on Saturday, March 1st! Havas’ Jennifer Tsitsopoulos, Practice Lead, Medical Anthropology, Havas Health Network, will sit down with Chris Shibutani MD MBA, MD, Global Investment Research, Pharmaceuticals, Goldman Sachs; and Ilan Szekely, Co-Founder & CEO, Telo Labs at the “Aesthetics & Medical: The GLP-1 Revolution” panel, moderated by Emily Safian-Demers, Director of Insights, Front Row. These industry leaders will discuss how GLP-1 medications are transforming consumer wellness, weight management, and beauty norms and what brands can do to adapt to these changes. Secure your spot here!: https://lnkd.in/eEDeTg5c #OneHavas #MeaningfulDifference

Grateful to Boston Globe Media for hosting today’s Rare Disease Summit. Expert speakers, important topics like newborn screening, health equity and legislation is just the start of the conversation. #RareDisease #RareDiseaseDay Havas Life Rare https://lnkd.in/excTtiGg